Severe congenital neutropenia mimicking chronic idiopathic neutropenia: a case report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Severe chronic neutropenia is classified as severe congenital, cyclic, autoimmune, or idiopathic. However, there is a lot of uncertainty regarding the diagnosis of severe congenital neutropenia (SCN) and chronic idiopathic neutropenia, and this uncertainty affects further evaluations and treatments. A 20-year-old man presented with fever and knee abrasions after a bicycle accident. On admission, his initial absolute neutrophil count (ANC) was 30/µL. He had no medical history of persistent severe neutropenia with periodic oscillation of ANC. Although his fever resolved after appropriate antibiotic therapy, ANC remained at 80/µL. Bone marrow (BM) aspiration and biopsy were performed, and a BM smear showed myeloid maturation arrest. Moreover, genetic mutation test results showed a heterozygous missense variant in exon 4 of the neutrophil elastase ELANE: c597+1G>C (pV190-F199del). The patient was diagnosed with SCN. After discharge, we routinely checked his ANC level and monitored any signs of infection with minimum use of granulocyte colony-stimulating factor (G-CSF), considering its potential risk of leukemic transformation. Considering that SCN can be fatal, timely diagnosis and appropriate management with G-CSF are essential. We report the case of a patient with SCN caused by ELANE mutation who had atypical clinical manifestations. For a more accurate diagnosis and treatment of severe chronic neutropenia, further studies are needed to elucidate the various clinical features of ELANE.
Abstract
Severe chronic neutropenia is classified as severe congenital, cyclic, autoimmune, or idiopathic. However, there is a lot of uncertainty regarding the diagnosis of severe congenital neutropenia (SCN) and chronic idiopathic neutropenia, and this uncertainty affects further evaluations and treatments. A 20-year-old man presented with fever and knee abrasions after a bicycle accident. On admission, his initial absolute neutrophil count (ANC) was 30/µL. He had no medical history of persistent severe neutropenia with periodic oscillation of ANC. Although his fever resolved after appropriate antibiotic therapy, ANC remained at 80/µL. Bone marrow (BM) aspiration and biopsy were performed, and a BM smear showed myeloid maturation arrest. Moreover, genetic mutation test results showed a heterozygous missense variant in exon 4 of the neutrophil elastase ELANE: c597+1G>C (pV190-F199del). The patient was diagnosed with SCN. After discharge, we routinely checked his ANC level and monitored any signs of infection with minimum use of granulocyte colony-stimulating factor (G-CSF), considering its potential risk of leukemic transformation. Considering that SCN can be fatal, timely diagnosis and appropriate management with G-CSF are essential. We report the case of a patient with SCN caused by ELANE mutation who had atypical clinical manifestations. For a more accurate diagnosis and treatment of severe chronic neutropenia, further studies are needed to elucidate the various clinical features of ELANE.
참고문헌 (20)
- Dale DC, "Severe chronic neutropenia : treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry", Am J Hematol, 72, pp.82~93 (2003)
- Wan C, "Clinical manifestations and outcomes of pediatric chronic neutropenia", J Formos Med Assoc, 111, pp.220~227 (2012)
- Donadieu J, "Congenital neutropenia : diagnosis, molecular bases and patient management", Orphanet J Rare Dis, 6, pp.26~ (2011)
- Boxer LA, "How to approach neutropenia", Hematology Am Soc Hematol Educ Program, 2012, pp.174~182 (2012)
- Walkovich K, "How to approach neutropenia in childhood", Pediatr Rev, 34, pp.173~184 (2013)
- Dale DC, "An update on the diagnosis and treatment of chronic idiopathic neutropenia", Curr Opin Hematol, 24, pp.46~53 (2017)
- Newburger PE, "Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype : evidence for phenotype determination by modifying genes", Pediatr Blood Cancer, 55, pp.314~317 (2010)
- Sicre de Fontbrune F, "Severe chronic primary neutropenia in adults : report on a series of 108 patients", Blood, 126, pp.1643~1650 (2015)
- Munshi HG, "Severe neutropenia : a diagnostic approach", West J Med, 172, pp.248~252 (2000)
- Kurnikova M, "Four novel ELANE mutations in patients with congenital neutropenia", Pediatr Blood Cancer, 57, pp.332~335 (2011)
- 조혜경, "Different Clinical Phenotypes in Familial Severe Congenital Neutropenia Cases with Same Mutation of the ELANE Gene", Journal of Korean Medical Science, 29(3), pp.452~455 (2014), 대한의학회
- Germeshausen M, "Mutations in the gene encoding neutrophil elastase(ELA2)are not sufficient to cause the phenotype of congenital neutropenia", Br J Haematol, 115, pp.222~224 (2001)
- Makaryan V, "The diversity of mutations and clinical outcomes for ELANE-associated neutropenia", Curr Opin Hematol, 22, pp.3~11 (2015)
- Gupta A, "Incidental chronic neutropenia in an asymptomatic adult", Cureus, 9, pp.e1779~ (2017)
- Solomou EE, "How to make the right diagnosis in neutropenia", Clin Hematol Int, 3, pp.41~46 (2021)
- Rotulo GA, "HSCT may lower leukemia risk in ELANE neutropenia : a before-after study from the French Severe Congenital Neutropenia Registry", Bone Marrow Transplant, 55, pp.1614~1622 (2020)
- Rotulo GA, "Recurrent bacterial infections, but not fungal infections, characterise patients with ELANE-related neutropenia : a French Severe Chronic Neutropenia Registry study", Br J Haematol, 194, pp.908~920 (2021)
- Dale DC, "A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor(filgrastim)for treatment of severe chronic neutropenia", Blood, 81, pp.2496~2502 (1993)
- Dale DC, "The discovery, development and clinical applications of granulocyte colony-stimulating factor", Trans Am Clin Climatol Assoc, 109, pp.27~36 (1998)
- Skokowa J, "Severe congenital neutropenias", Nat Rev Dis Primers, 3, pp.17032~ (2017)